Description
This assay uses the Luminex® 200™ platform.
Our most popular mouse array, consider this assay for an extensive cytokine and chemokine profile in mouse models. The Mouse Cytokine/Chemokine 32-Plex Discovery Assay® Array (MD32) measures 32 biomarkers simultaneously from a small sample volume, including IL-6, TNFα, and VEGF-A, providing a broad view of immune responses and inflammatory pathways.
Ideal for studying complex conditions such as cancer, autoimmune diseases, and chronic infections, this assay helps elucidate interactions between cytokines and chemokines. For instance, VEGF-A is significant in tumor angiogenesis, while IL-6 and TNFα are involved in inflammation and immune regulation.
If you anticipate that your samples may have low cytokine levels, such as those from normal healthy populations, you might want to consider our High Sensitivity panel. This advanced option is specifically designed to detect low abundance cytokines with greater precision, ensuring you capture even subtle variations in your data.
Discover the power of precision with our assay, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency. Streamline your research and unlock a new level of detail with our advanced multiplex assay solution.
Recommended Dilution: The kit manufacturer recommends Serum and Plasma be run at a 2-fold dilution. If you wish to run your samples at a dilution, predilute your samples with PBS pH~7.5. See our Sample Dilution Guide for more information.
If you expect your samples to have low cytokine levels, i.e. normal healthy populations, you may wish to inquire about a High Sensitivity panel.
Click here for information on shipping biological samples for Discovery Assays
Published Research Featuring Our MD32:
- Xie, Q., Namba, M. D., Buck, L. A., Park, K., Jackson, J. G., & Barker, J. M. (2024). Effects of antiretroviral treatment on central and peripheral immune response in mice with EcoHIV infection. Cells, 13(10), 882.
- Saranchova, I., Xia, C. W., Besoiu, S., Finkel, P. L., Ellis, S. L. S., Kari, S., Munro, L., Pfeifer, C. G., Fazli, L., Gleave, M. E., & Jefferies, W. A. (2024). A novel type-2 innate lymphoid cell-based immunotherapy for cancer. Frontiers in Immunology, 15.
- Allen-Gondringer, A., Gau, D., Dutta, P., & Roy, P. (2024). Haplo-insufficiency of profilin1 in vascular endothelial cells is beneficial but not sufficient to confer protection against experimentally induced atherosclerosis. Cytoskeleton.